Inhalers & Asthma Medication recalls
The FDA has published 95 recalls involving inhalers & asthma medication since 2012. The latest was reported on 17 Jun 2026. Most were for manufacturing (cgmp) deviations. Integrated Health Concepts has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls95since 2012
Last 12 months2reported
Class I44% of total
Ongoing13latest 17 Jun 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 4 4%Class II 75 79%Class III 16 17%
Why inhalers & asthma medication is recalled
Companies
Brands
By year
Ongoing inhalers & asthma medication recalls
13 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Budesonide Inhalation Suspension, 1mg recalledBudesonide | Sun Pharmaceutical Industries | Particulate Matter | Nationwide |
| Drug | CLASS II | Albuterol Sulfate Inhalation Solution, 5%, 25 mg recalled by Nephron SC | Nephron SC | Sterility | Nationwide |
| Drug | CLASS III | Albuterol Sulfate, Inhalation Aerosol, 90 mcg recalled by Cipla USAAlbuterol Sulfate | Cipla USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Budesonide Inhalation Suspension, 5mg/-dose ampules per, five recalledBudesonide | Cipla USA | Sterility | Nationwide |
| Drug | CLASS II | Airsupra (albuterol and budesonide) inhalation aerosol recalledAirsupra | AsttraZeneca Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Budesonide Extended-Release Tablets 9mg recalledBudesonide | Teva Pharmaceuticals USA | Potency & Assay | Nationwide |
All inhalers & asthma medication recalls, newest first
95 totalShould you stop taking Inhalers & Asthma Medication?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.